https://interactions.guidetherapeutiquevih.com/en/interaction-details?id=9785
No pharmaceutical opinion available for this interaction.
Phenobarbital can induce the metabolism (CYP 3A4) and decrease the plasma concentration of Elvitegravir / Cobicistat.
Possible decrease of clinical efficacy.
Risk of a possible development of resistance to antiretroviral class.
Avoid this association or monitor for signs and symptoms of therapeutic failure.
–
–
Contraindicated. Use alternative.
Gabapentin, pregabalin, leviracetam.
–
Viral Load
Elvitegravir plasma level
CD4+
–
See elvitegravir/cobicistat + carbamzepine.